Jun 03, 2020
QCDx Announces Clinical Study for the Determination of Clinical Utility of the QCDx-br(TM) Liquid Biopsy System to Optimize Treatment Options for Breast Cancer
Apr 06, 2020
Global Minimally Invasive Biopsy Technologies Markets, 2019-2030 - A $4+ Billion Opportunity with Focus on Liquid Biopsy, Optical Biopsy, and Brush Biopsy, Pigmented Lesion Assays, and Breath Biopsy
Feb 25, 2020
Circulating Tumor Cell (CTC) Isolation & Detection, 2020: Patent Landscape, IP Position of Main Patent Applicants, Key Patents, Patent Segmentation, and IP Profile of Key Players
Feb 13, 2020
Trovagene Presents Phase 2 Data Demonstrating the Ability of Onvansertib to Overcome Zytiga®-Resistance and Provide Clinical Benefit for mCRPC Patients
Jan 21, 2020
QCDx Announces Sale of the RareScope to the Carole and Ray Neag Comprehensive Cancer Center at UConn Health for Use in Clinical Research
Jan 06, 2020
Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers
Dec 10, 2019
The global cell separation market at a CAGR of over 17% during the forecast period
Dec 09, 2019
New Menarini CELLSEARCH Studies to be Presented at San Antonio Breast Cancer Symposium
Dec 05, 2019
Epic Sciences to Present New Data Showing Feasibility of its Liquid Biopsy Test in Breast Cancer
Nov 05, 2019
The Non-invasive Cancer Diagnostics Market is Projected to Grow at Annualized Rate of Nearly 20%, Between 2019 and 2030, Claims Roots Analysis
Oct 31, 2019
RareCyte expands liquid biopsy offering with the release of a HER2/ER breast cancer CTC Panel Kit
Oct 30, 2019
RareCyte launches prostate cancer ARv7 CTC Kit for liquid biopsy analysis
Oct 30, 2019
Global Liquid Biopsy Market 2019 Analysis by Biomarkers, Cancer Type, Regions, Key Profiles and Forecasts to 2024 Report by ReportsnReports
Oct 29, 2019
New RarePlex Developer Kits for CTC characterization provide researchers flexibility in independent CTC assay development
Oct 03, 2019
Biocept Announces Issuance of South Korean Patent Covering its Target Selector(TM) Oncogene Mutation Enrichment and Detection Platform
Aug 12, 2019
New Publication Shows Different Result of Risk Classification between GenesWell BCT and Oncotype DX in Breast Cancer Patients 50 Years Old or Younger.
May 30, 2019
Published Study Demonstrates Feasibility of a Blood Test to Predict Disease Progression and Metastasis in Localized Prostate Cancer
May 28, 2019
CELLSEARCH Studies at ASCO Show Potential Predictive Role for Circulating Tumor Cells in Metastatic Breast Cancer
May 28, 2019
Biocept Awarded Patent in China for its Circulating Tumor Cell Platform Expanding Intellectual Property Estate to 33 Issued Patents Globally
May 15, 2019
Epic Sciences to Present New Data Identifying Multiple Cancer Biomarkers Associated with Treatment Response in Prostate and Bladder Cancer at ASCO 2019